News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Aaron Ritter, MD

Articles by Aaron Ritter, MD

Laflor2000/peopleimages.com/Adobe Stock

Making Sense of the New Alzheimer Treatment Landscape, With Aaron Ritter, MD

ByJessica Walters,Aaron Ritter, MD

July 30th 2026

How can new Alzheimer therapies benefit patients today?

Latest Updated Articles

Trending on Psychiatric Times

Can Psychiatry Lead in Building Brain Capital? Why Mental Health Matters for Policy, Economy, and Society

Categories vs Dimensions: Wave or Particle?

PET Imaging Confirms Lower Muscarinic M1 Receptor Availability in Schizophrenia

Preventing Alzheimer Disease After Brain Injury: Targeting TNF With XPro1595

TNX-102 SL in Major Depressive Disorder: Targeting Slow-Wave Sleep